Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has shared an announcement.
Shanghai HeartCare Medical Technology Corporation Limited has issued a positive profit alert, expecting a net profit of not less than RMB40 million for the first half of 2025. This financial turnaround is attributed to increased revenue from new and existing stroke treatment devices, effective cost control measures, and gains in financial assets. The company is still finalizing its interim results, and the figures are subject to adjustments.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company based in China that specializes in medical technology, particularly focusing on the development and sales of stroke treatment devices. The company is involved in creating innovative solutions for hemorrhagic and ischemic stroke treatments.
Average Trading Volume: 146,367
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.94B
See more data about 6609 stock on TipRanks’ Stock Analysis page.